Oh no, you're thinking, yet another cookie pop-up. Well, sorry, it's the law. We measure how many people read us, and ensure you see relevant ads, by storing cookies on your device. If you're cool with that, hit “Accept all Cookies”. For more info and to customize your settings, hit “Customize Settings”.

Review and manage your consent

Here's an overview of our use of cookies, similar technologies and how to manage them. You can also change your choices at any time, by hitting the “Your Consent Options” link on the site's footer.

Manage Cookie Preferences
  • These cookies are strictly necessary so that you can navigate the site as normal and use all features. Without these cookies we cannot provide you with the service that you expect.

  • These cookies are used to make advertising messages more relevant to you. They perform functions like preventing the same ad from continuously reappearing, ensuring that ads are properly displayed for advertisers, and in some cases selecting advertisements that are based on your interests.

  • These cookies collect information in aggregate form to help us understand how our websites are being used. They allow us to count visits and traffic sources so that we can measure and improve the performance of our sites. If people say no to these cookies, we do not know how many people have visited and we cannot monitor performance.

See also our Cookie policy and Privacy policy.

This article is more than 1 year old

Bad back? Show some spine and stop popping paracetamol

Study finds common pain-killer doesn't reduce pain or shorten recovery

The human spine is poorly-designed for the rigours of modern life, but so are the drugs most commonly prescribed to help you endure a bad back.

That's the conclusion of a new study looking into whether paracetamol, the drug most often suggested to treat bad backs, actually helps.

Reported in The Lancet, the study funded by the National Health and Medical Research Council of Australia and pharmaceutical company GlaxoSmithKline Australia ran for over three years and involved “a multicentre, double-dummy, randomised, placebo controlled trial across 235 primary care centres in Sydney.”

The study saw some patients given regular doses paracetamol, others told to take the drug when in pain and a third group handed placebos.

Those given paracetamol, in either mode, reported no less pain than those taking placebos. Nor did sugar-pill-poppers recover from their ailments more slowly.

The authors therefore “question the universal endorsement of paracetamol in this patient group.”

In this interview the study's leader Professor Chris Maher even questions whether Paracetamol can be considered a pain-killer.

“The jury is out” on whether the drug lessens pain, Professor Maher says about two minutes into the interview.

Whether or not the drug works may be moot, Professor Maher adds, because paracetamol is usually prescribed along with instructions not to lie around in bed waiting for a bad back to stop hurting. He therefore hypothesises that merely being told to stay up and about, made possible by the fact one is taking pain-killers, could be the best therapy of all. ®

 

Similar topics

TIP US OFF

Send us news


Other stories you might like